Company: Gate Neurosciences, Inc.
Job title: Co-Founder, President & Chief Executive officer
Unlocking Event-Driven Pharmacology: New Translational Data Supporting Clinical Development of the ‘Stinels’, a Novel Class of NMDAR Modulators 1:40 pm
Enhancing synaptic function through direct NMDAR-mediated mechanism shows rapid and durable anti-depressant effect Using translational tools to predict and test dose model, confirmed through clinical qEEG biomarkers now with a second molecule in the classRead more
day: Conference Day One